KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Receivables (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Change in Receivables for 11 consecutive years, with $29.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 290.49% year-over-year to $29.1 million, compared with a TTM value of $106.2 million through Dec 2025, up 4837.51%, and an annual FY2025 reading of $106.2 million, up 4837.51% over the prior year.
  • Change in Receivables was $29.1 million for Q4 2025 at Medpace Holdings, up from -$4.9 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $79.9 million in Q2 2025 and bottomed at -$19.1 million in Q1 2024.
  • Average Change in Receivables over 5 years is $12.2 million, with a median of $6.7 million recorded in 2022.
  • The sharpest move saw Change in Receivables surged 7103.12% in 2022, then plummeted 540.06% in 2024.
  • Year by year, Change in Receivables stood at -$64000.0 in 2021, then soared by 7103.12% to $4.5 million in 2022, then skyrocketed by 100.09% to $9.0 million in 2023, then plummeted by 270.32% to -$15.3 million in 2024, then surged by 290.49% to $29.1 million in 2025.
  • Business Quant data shows Change in Receivables for MEDP at $29.1 million in Q4 2025, -$4.9 million in Q3 2025, and $79.9 million in Q2 2025.